对 40例恶性肿瘤病人采用抗肿瘤药物联合化疗的同时配以氧透射载体治疗 ,防止血像下降总有效率达 89% ;血浆中超氧化物岐化酶(SOD)的活性治疗后显著升高 ,对照组及治疗前比较有统计学意义 (P <0 0 1 )。统计学表明治疗前后患者的临床症状及血像的改变差异显著。此方法操作简便、无副作用 ,为肿瘤病人联合化疗和延长生存期创造了条件。 40 cases of malignant tumor patients using anti-tumor drug combined with chemotherapy combined with oxygen transmission carrier treatment to prevent the total reduction of blood loss was 89%; plasma superoxide dismutase (SOD) activity was significantly increased after treatment, The control group and before treatment were statistically significant (P <0.01). Statistics show that patients before and after treatment of clinical symptoms and changes in significant differences in blood. This method is easy to operate and has no side effects, which creates the conditions for combined treatment of cancer patients and prolongation of survival.